Tech Company Financing Transactions

Libra Therapeutics Funding Round

Libra Therapeutics secured a $29 million Series A funding round on 9/24/2020. Investors included Boehringer Ingelheim Venture Fund, Epidarex Capital and Sante Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
San Diego, CA 92130
USA

Phone

Undisclosed

Website

www.libratherapeutics.com

Email Address

[email protected]

Overview

Libra Therapeutics is focused on developing novel disease-modifying therapeutics that can restore the cellular balance disrupted in neurodegenerative diseases. These include amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer's, Parkinson's, and Huntington's disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Isaac Veinbergs

        

Browse more venture capital transactions:

Prev: 9/24/2020: Silverback Therapeutics venture capital transaction
Next: 9/24/2020: Meallogix venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary